Telemetry Investments’s Johnson & Johnson JNJ Stock Holding History

Telemetry Investments’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,000	Closed	-$645K	–	127
2018 Q4	$645K	Hold	5,000	–	–	0.41%	61
2018 Q3	$691K	Hold	5,000	–	–	0.31%	50
2018 Q2	$607K	Hold	5,000	–	–	0.23%	53
2018 Q1	$641K	Buy	+5,000	New	+$676K	0.24%	68

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Telemetry Investments's JNJ Position: Q1 2019 in Review

Telemetry Investments sold out of Johnson & Johnson (JNJ) in Q1 2019, closing a stake of 6,845 shares — an estimated $883K sold.

Telemetry Investments first reported a position in JNJ in Q4 2014 and held it in 5 quarters. The position peaked at $883K in Q4 2018. 2,766 funds tracked by Wall St. Rank hold JNJ as of Q1 2019.

Telemetry Investments reported no remaining Johnson & Johnson position as of Q1 2019 after selling out during the quarter.
Telemetry Investments sold 6,845 Johnson & Johnson shares in Q1 2019, an estimated $883K.
Telemetry Investments first reported a position in Johnson & Johnson in Q4 2014 and held it in 5 quarters.
Telemetry Investments's Johnson & Johnson position peaked at $883K in Q4 2018.
2,766 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2019.

Based on Telemetry Investments's 13F filing for Q1 2019, filed 15 May 2019.